These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1322547)

  • 21. PET versus SPECT in distinguishing radiation necrosis from tumor recurrence in the brain.
    Buchpiguel CA; Alavi JB; Alavi A; Kenyon LC
    J Nucl Med; 1995 Jan; 36(1):159-64. PubMed ID: 7799071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.
    Kahn D; Follett KA; Bushnell DL; Nathan MA; Piper JG; Madsen M; Kirchner PT
    AJR Am J Roentgenol; 1994 Dec; 163(6):1459-65. PubMed ID: 7992747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FDG-PET in the selection of brain lesions for biopsy.
    Hanson MW; Glantz MJ; Hoffman JM; Friedman AH; Burger PC; Schold SC; Coleman RE
    J Comput Assist Tomogr; 1991; 15(5):796-801. PubMed ID: 1885797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positron emission tomography-guided stereotactic brain biopsy.
    Levivier M; Goldman S; Bidaut LM; Luxen A; Stanus E; Przedborski S; Balériaux D; Hildebrand J; Brotchi J
    Neurosurgery; 1992 Oct; 31(4):792-7; discussion 797. PubMed ID: 1407471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of positron emission tomography to neurological oncology.
    Chin HW; Fruin AH; Bertoni JM; Frick MP; Shiue CY; McClellan G; Lefkowitz D; Taylon C; Boman BM
    Nebr Med J; 1991 Mar; 76(3):70-3. PubMed ID: 1851543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical application of positron emission tomography and 18FDG to brain tumor].
    Momose T
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():242-9. PubMed ID: 16201530
    [No Abstract]   [Full Text] [Related]  

  • 27. PET: brain tumor biochemistry.
    Roelcke U
    J Neurooncol; 1994; 22(3):275-9. PubMed ID: 7760107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Kinetic analysis of glucose metabolism in meningiomas--comparison with malignant gliomas].
    Shioya H; Mineura K; Sasajima T; Kowada M; Iida H; Ogawa T; Hatazawa J; Uemura K
    No To Shinkei; 1995 Jun; 47(6):549-56. PubMed ID: 7605682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SPECT studies of brain tumors with L-3-[123I] iodo-alpha-methyl tyrosine: comparison with PET, 124IMT and first clinical results.
    Langen KJ; Coenen HH; Roosen N; Kling P; Muzik O; Herzog H; Kuwert T; Stöcklin G; Feinendegen LE
    J Nucl Med; 1990 Mar; 31(3):281-6. PubMed ID: 2155314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo metabolism of childhood posterior fossa tumors and primitive neuroectodermal tumors before and after treatment.
    Holthoff VA; Herholz K; Berthold F; Widemann B; Schröder R; Neubauer I; Heiss WD
    Cancer; 1993 Aug; 72(4):1394-403. PubMed ID: 8339230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positron emission tomographic evaluations in the diagnosis and therapy of multifocal glioblastoma. Report of a pediatric case.
    Mineura K; Yasuda T; Kowada M; Sakamoto T; Ogawa T; Shishido F; Uemura K
    Pediatr Neurosci; 1985-1986; 12(4-5):208-12. PubMed ID: 3039475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroimaging of juvenile pilocytic astrocytomas: an enigma.
    Fulham MJ; Melisi JW; Nishimiya J; Dwyer AJ; Di Chiro G
    Radiology; 1993 Oct; 189(1):221-5. PubMed ID: 8372197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introduction to imaging brain tumor metabolism with positron emission tomography (PET).
    Conti PS
    Cancer Invest; 1995; 13(2):244-59. PubMed ID: 7874578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET.
    Kim EE; Chung SK; Haynie TP; Kim CG; Cho BJ; Podoloff DA; Tilbury RS; Yang DJ; Yung WK; Moser RP
    Radiographics; 1992 Mar; 12(2):269-79. PubMed ID: 1561416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positron emission tomography and brain tumours.
    Goldman S; Wikler D; Damhaut P; Monclus M; Levivier M; Pirotte B; De Witte O; Brotchi J; Hildebrand J
    Acta Neurol Belg; 1997 Sep; 97(3):183-6. PubMed ID: 9345590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain metastases from non-central nervous system tumors: evaluation with PET.
    Griffeth LK; Rich KM; Dehdashti F; Simpson JR; Fusselman MJ; McGuire AH; Siegel BA
    Radiology; 1993 Jan; 186(1):37-44. PubMed ID: 8416584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical indications for PET of the central nervous system: primary brain tumors, vascular and degenerative dementia].
    Bicik I; von Schulthess GK
    Schweiz Rundsch Med Prax; 1993 Aug; 82(34):905-9. PubMed ID: 8372294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors.
    Janus TJ; Kim EE; Tilbury R; Bruner JM; Yung WK
    Ann Neurol; 1993 May; 33(5):540-8. PubMed ID: 8498831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective evaluation of thallium-201 single photon emission computerized tomography for brain tumor burden.
    Lorberboym M; Baram J; Feibel M; Hercbergs A; Lieberman L
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):249-54. PubMed ID: 7721624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-11 methionine and F-18 FDG uptake in a patient with meningioma and glioblastoma multiforme.
    Korkmaz M; Kim EE; Wong FC; Podoloff DA
    Clin Nucl Med; 1996 Jul; 21(7):580-2. PubMed ID: 8818480
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.